Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Kulkarni, Ritwij ^a,c   Dhakal, Bijaya K ^b   Slechta, E Susan ^b   Kurtz, Zachary ^a   Mulvey, Matthew A ^b   Thanassi, David G ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SECRETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BLADDER EPITHELIUM; CBA MOUSE; CELL INVASION; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; EXPERIMENTAL INFECTION; FEMALE; GENE CLUSTER; GENE DELETION; HUMAN; HUMAN CELL; KIDNEY CELL; KNOCKOUT GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN FUNCTION; TISSUE CULTURE; TYPE II SECRETION SYSTEM; TYPE IV PILUS SYSTEM; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BLADDER; CELL CULTURE; CYTOLOGY; CYTOTOXICITY TEST; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KIDNEY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

ANIMALS; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTERLEUKIN-6; KIDNEY; MICE; MICE, INBRED CBA; MICE, KNOCKOUT; PHENOTYPE; SECRETIN; URINARY BLADDER; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 62749195579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004752     Document Type: Article

References (44)

1. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
2. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49: 53-70.
3. Foxman B, Brown P (2003) Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17: 227-241.
4. Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 Suppl 1A: 14S-19S.
5. Landraud L, Pulcini C, Gounon P, Flatau G, Boquet P, et al. (2004) E. coli CNF1 toxin: a two-in-one system for host-cell invasion. Int J Med Microbiol 293: 513-518.
6. Davis JM, Rasmussen SB, O'Brien AD (2005) Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 73: 5301-5310.
7. Guignot J, Chaplais C, Coconnier-Polter MH, Servin AL (2007) The secreted autotransporter toxin, Sat, functions as a virulence factor in Afa/Dr diffusely adhering Escherichia coli by promoting lesions in tight junction of polarized epithelial cells. Cell Microbiol 9: 204-221.
8. Guyer DM, Radulovic S, Jones FE, Mobley HL (2002) Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 70: 4539-4546.
9. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282: 1494-1497.
10. Bock K, Breimer ME, Brignole A, Hansson GC, Karlsson KA, et al. (1985) Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1-4Gal-containing glycosphingolipids. J Biol Chem 260: 8545-8551.
11. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. Embo J 19: 2803-2812.
12. McTaggart LA, Rigby RC, Elliott TS (1990) The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. J Med Microbiol 32: 135-141.
13. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, et al. (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301: 105-107.
14. Justice SS, Lauer SR, Hultgren SJ, Hunstad DA (2006) Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 74: 4793-4800.
15. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97: 8829-8835.
16. Jiang B, Howard SP (1992) The Aeromonas hydrophila exeE gene, required both for protein secretion and normal outer membrane biogenesis, is a member of a general secretion pathway. Mol Microbiol 6: 1351-1361.
17. Hales LM, Shuman HA (1999) Legionella pneumophila contains a type II general secretion pathway required for growth in amoebae as well as for secretion of the Msp protease. Infect Immun 67: 3662-3666.
18. Sandkvist M, Michel LO, Hough LP, Morales VM, Bagdasarian M, et al. (1997) General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J Bacteriol 179: 6994-7003.
19. Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM (2002) Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A 99: 7066-7071.
20. Pugsley AP, Francetic O, Possot OM, Sauvonnet N, Hardie KR (1997) Recent progress and future directions in studies of the main terminal branch of the general secretory pathway in Gram-negative bacteria-a review. Gene 192: 13-19.
21. Nouwen N, Ranson N, Saibil H, Wolpensinger B, Engel A, et al. (1999) Secretin PulD: association with pilot PulS, structure, and ion-conducting channel formation. Proc Natl Acad Sci U S A 96: 8173-8177.
22. Py B, Loiseau L, Barras F (2001) An inner membrane platform in the type II secretion machinery of Gram-negative bacteria. EMBO Rep 2: 244-248.
23. Vignon G, Kohler R, Larquet E, Giroux S, Prevost MC, et al. (2003) Type IV-like pili formed by the type II secreton: specificity, composition, bundling, polar localization, and surface presentation of peptides. J Bacteriol 185: 3416-3428.
24. Sandkvist M (2001) Type II secretion and pathogenesis. Infect Immun 69: 3523-3535.
25. Bose N, Payne SM, Taylor RK (2002) Type 4 pilus biogenesis and type II-mediated protein secretion by Vibrio cholerae occur independently of the TonB-facilitated proton motive force. J Bacteriol 184: 2305-2309.
26. Paranjpye RN, Strom MS (2005) A Vibrio vulnificus type IV pilin contributes to biofilm formation, adherence to epithelial cells, and virulence. Infect Immun 73: 1411-1422.
27. Francetic O, Belin D, Badaut C, Pugsley AP (2000) Expression of the endogenous type II secretion pathway in Escherichia coli leads to chitinase secretion. Embo J 19: 6697-6703.
28. Zalewska-Piatek B, Bury K, Piatek R, Bruzdziak P, Kur J (2008) Type II secretory pathway for surface secretion of DraD invasin from the uropathogenic Escherichia coli Dr+ strain. J Bacteriol 190: 5044-5056.
29. Sauvonnet N, Gounon P, Pugsley AP (2000) PpdD type IV pilin of Escherichia coli K-12 can Be assembled into pili in Pseudomonas aeruginosa. J Bacteriol 182: 848-854.
30. Sauvonnet N, Vignon G, Pugsley AP, Gounon P (2000) Pilus formation and protein secretion by the same machinery in Escherichia coli. Embo J 19: 2221-2228.
31. Xicohtencatl-Cortes J, Monteiro-Neto V, Ledesma MA, Jordan DM, Francetic O, et al. (2007) Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest 117: 3519-3529.
32. Xicohtencatl-Cortes J, Monteiro-Neto V, Saldana Z, Ledesma MA, Puente JL, et al. (2009) The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes. J Bacteriol 191: 411-421.
33. Giron JA, Levine MM, Kaper JB (1994) Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli. Mol Microbiol 12: 71-82.
34. Giron JA, Ho AS, Schoolnik GK (1991) An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 254: 710-713.
35. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, et al. (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58: 1281-1289.
36. Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572-4579.
37. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99: 17020-17024.
38. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, et al. (2006) Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A 103: 5977-5982.
39. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645.
40. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ (2005) Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73: 3999-4006.
41. Hagberg L, Engberg I, Freter R, Lam J, Olling S, et al. (1983) Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 40: 273-283.
42. Lane MC, Alteri CJ, Smith SN, Mobley HL (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104: 16669-16674.
43. Merz AJ, So M (2000) Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol 16: 423-457.
44. Morales VM, Backman A, Bagdasarian M (1991) A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants. Gene 97: 39-47.